Request for Proposals (RFP) to Host Annual EAHAD Congress 2029
Are you a clinician actively involved in the haemophilia and bleeding disorders field and a dedicated member of EAHAD? If so, we're happy to inform you that we've just launched the EAHAD 2029 Request for Proposals (RFP)!
EAHAD is a multidisciplinary association comprising healthcare professionals from…
Nurses Committee Newsletter
Spring 2025
EAHAD 2025 Congress • Nurses Committee Webinar: "How to do a literature search in databases" • Highlights from EAHAD Working Groups • European Principles of Nursing Care for Persons With Inherited Bleeding Disorders • Save the Date
EAHAD 2025 Congress
Allied Healthcare Professional Day Recap
During the Allied Healthcare Professional…
Gene therapy represents one of the most significant advancements in the treatment of bleeding disorders. By offering the potential for durable improvements in clotting factor levels with a single infusion, this innovative approach has opened new possibilities for people living with haemophilia and allied conditions. While gene therapy is still evolving, the progress made to…
Brussels, Belgium, 18 February 2025 - The European Association for Haemophilia and Allied Disorders (EAHAD) is delighted to announce the successful conclusion of its 2025 Congress, held from 4 to 7 February in Milan, Italy. With nearly 2,200 delegates from over 78 countries, the Congress, under the leadership of President Prof. Flora Peyvandi, provided an…
Haemophilia marks a significant milestone in 2024—three decades since its inception. Since its first issue in October 1994, the esteemed publication has been a vital platform for sharing knowledge on the comprehensive care of haemophilia and fostering collaboration across disciplines. The journal became WFH’s official publication in 1992, and in 2007, became our official journal,…
The European Association for Haemophilia and Allied Disorders (EAHAD) commends the International Society's on Thrombosis and Haemostasis (ISTH) initiative to publish evidence-based guidelines. These guidelines have been subject to considerable discussion, with numerous clinicians and organisations expressing concerns, and we acknowledge the disquiet within the wider community. Nevertheless, it is crucial to remember that guidelines are…
Page (post) title HomePage (post) title
Recent advancements in hemophilia treatment have shifted the focus from survival to preventing musculoskeletal complications and improving quality of life. Even minimal joint bleeding can cause damage, but recognizing subclinical bleeding remains a challenge, leading to misdiagnosis and suboptimal care. The purpose of the Joint Health in Inherited Bleeding Disorders…
The European Association for Haemophilia and Allied Disorders is inviting haemophilia specialists to apply for two (2) posts on its Gene Therapy Working Group. The positions are for a three-year term that would begin in February 2025.
If you are interested in applying, please send a short letter of motivation (maximum 300 words) outlining why…
We are very happy to inform you about a great opportunity to help delegates with limited access to funding: The Virtual Access Grants!
Physicians and scientists, PhD students, post-doctoral researchers, nurses, physiotherapists, psychosocial professionals and other allied healthcare professionals primarily from low and middle-income countries (LMICs) will get the chance to join EAHAD 2025 online…
Join the EAHAD Social Media Ambassadors Programme for EAHAD 2025!
APPLY NOW
The Social Media Ambassador Programme aims to enhance EAHAD’s mission of ensuring the provision of the highest quality of clinical care, educating the medical community and the general public, and promoting scientific research in the field of haemophilia and allied disorders. Mission & Goals…
